Eclipse Therapeutics, Inc., a biotechnology company dedicated to the discovery and development of novel therapeutics that target cancer stem cells, announced today the appointments of Hans Clevers,...
(PRWeb February 01, 2012)
Read the full story at http://www.prweb.com/releases/2012/2/prweb9155733.htm
Comments on this entry are closed.